Bio-Technology General Euflexxa 1% Sodium Hyaluronate

Država: Singapur

Jezik: angleščina

Source: HSA (Health Sciences Authority)

Dostopno od:

FERRING PHARMACEUTICALS PRIVATE LIMITED

Razred:

Class D medical device

Izdeluje:

Bio-Technology General (Israel) Ltd.

Terapevtsko območje:

Orthopaedics

Terapevtske indikacije:

EUFLEXXA is indicated for the treatment of pain caused by osteoarthritis of the knee, hip, temporomandibular, carpometacarpal, shoulder and ankle joints. EUFLEXXA aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.

Povzetek izdelek:

Device System Info:[Sterile Medical Device], EUFLEXXA is packed in a single-use, aseptically-filled disposable sterile 2.25 ml syringe (nominal volume) containing either 1 ml or 2 ml of 1% microbial fermentation-derived NaHA in phosphate-buffered saline; Models: Euflexxa 1% Sodium Hyaluronate - 3 x 2ml, Euflexxa 1% Sodium Hyaluronate - 1 x 2ml

Datum dovoljenje:

2017-04-28